tiprankstipranks
Trending News
More News >
Protagonist Therapeutics Inc (PTGX)
NASDAQ:PTGX
US Market

Protagonist Therapeutics (PTGX) Ownership - Who Owns Protagonist Therapeutics?

Compare
730 Followers

Protagonist Therapeutics (PTGX) Ownership Overview

1.47%17.39%0.35%22.22%58.56%
0.35% Other Institutional Investors
22.22% ETFs
58.56% Public Companies and Individual Investors
The ownership structure of Protagonist Therapeutics (PTGX) stock is a mix of institutional, retail, and individual investors. Approximately 39.97% of the company’s stock is owned by Institutional Investors, 1.47% is owned by Insiders, and 58.56% is owned by Public Companies and Individual Investors.
The ownership structure of Protagonist Therapeutics (PTGX) stock is a mix of institutional, retail, and individual investors. Approximately 17.74% of the company’s stock is owned by Institutional Investors, 1.47% is owned by Insiders, and 22.22% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 27, 2026
xxxxxxxxxxxxx
$4063743
Jan 27, 2026
xxxxxxxxxxxxx
$3841037
Jan 27, 2026
xxxxxxxxxxxxx
$1905305
Jan 21, 2026
xxxxxxxxxxxxx
$2840446

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2025
xxxxxxxxxxxxx
$62510
Sep 30, 2025
xxxxxxxxxxxxx
$1128579
Sep 30, 2025
xxxxxxxxxxxxx
$1395030
Sep 30, 2025
xxxxxxxxxxxxx
$10608871

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,782,409Institution10.85%574,809,163
6,196,006Institution9.91%525,111,509
3,347,103Institution5.35%283,666,979
2,572,947Institution4.12%218,057,258
2,087,453Institution3.34%176,911,642
1,438,247Institution2.30%121,891,433
1,139,854Institution1.82%96,602,627
1,062,977Institution1.70%90,087,301
1,030,134Institution1.65%87,303,857
913,443Institution1.46%77,414,294

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,572,947Institution4.12%218,057,258
1,062,977Institution1.70%90,087,301
913,443Institution1.46%77,414,294
633,874Institution1.01%53,720,822
623,950Institution1.00%52,879,763
431,500Institution0.69%36,569,625
429,113Institution0.69%36,367,327
414,868Institution0.66%35,160,063
407,487Institution0.65%34,534,523
342,260Institution0.55%29,006,535

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,494,407Institution5.59%296,150,993
1,961,878Institution3.14%171,350,425
1,434,535Institution2.29%121,576,841
1,103,077Institution1.76%94,015,253
708,784Institution1.13%61,905,195
633,556Institution1.01%55,334,781
527,569Institution0.84%44,964,706
504,287Institution0.81%42,738,323
485,288Institution0.78%41,128,158
436,509Institution0.70%36,994,138

FAQ

Who Owns Protagonist Therapeutics Inc (PTGX)?
According to the latest TipRanks data, approximately 0.35% of the company's stock is held by institutional investors, 1.47% is held by insiders, and 58.56% is held by retail investors.
    What percentage of Protagonist Therapeutics Inc (PTGX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.35% of Protagonist Therapeutics Inc (PTGX) stock is held by institutional investors.
      What percentage of Protagonist Therapeutics Inc (PTGX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 58.56% of Protagonist Therapeutics Inc (PTGX) stock is held by retail investors.
        Who owns the most shares of Protagonist Therapeutics Inc (PTGX)?
        iShares owns the most shares of Protagonist Therapeutics Inc (PTGX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.